If their Pipeline was so good; why was a small little biotech like Biodel the only ones willing to invest in their company. I would think if their pipeline was so great; big pharma would be all over it??
I agree it is very disappointing. If they are not even moving forward with their Diabetes pipeline; it seems like Albirero just merged with Biodel for access to their cash. Even if Biodel sells their pipeline; the cash will be used towards Albireo's pipeline which we know nothing about. Would like to know what the new stock will open up at. We will only get on 1/3 the shares of that price.
The only hope is if this company Albireo becomes successful which I know nothing about. Even if we sell our pipeline; the funds will be used towards their pipeline. Wish I sold today at .52. Not sure what to do here?
Very small company. If you look on their website; they are bragging about initially raising $40M which isn't a lot of money. They essentially will be raising almost that by merging with Biodel. Biodel doesn't seem to be getting much out of the deal except for funding another company. Still own my shares, but my hope of making money of those has dwindled.
It seems like Albireo merged with Biodel just for the cash. No mention of using their pipeline. I was holding my shares for a buyout/merger, but not liking this deal so far. Seems like we are just using our cash to help out another small company's pipeline?